18 East 41st Street Suite 1503
New York, N.Y. 10027
GLOBAL DYNAMICS TECHNOLOGY
All interested accredited investors can inquire about how you can invest in our NTD project. Please click above to review our executive summary, and can send us a message from our contact page for additional information.
Future Research and Development
Research and development investment in the domestic sector remains more than twice the average for all U.S. manufacturers. The US holds a competitive advantage that the medical industry relies on, medical devices such as microelectronics and neuro-stimulators are fueled by innovation and the ongoing quest for better ways of treating or diagnosing medical problems. The United States remains the largest medical device market in the world with a market size of around $110 billion, and it is expected to reach $133 billion by 2016. The U.S. market value represented about 38 percent of the global medical device market in 2012. U.S. exports of medical devices in key product categories identified by the Department of Commerce exceeded $44 billion in 2012, a more than 7 percent increase from the previous year.
The future growth of this sector remains positive.
Global Dynamics Technology a New York City Corporation is a start company since Augist 2015. It's sister company Dynamic Sports Therapy a healthcare facility has been existence since 2005. GDTI is organized to do product designs and development, electrical and machanical engineering consulting and professional consulting services. GDTI, we innovate, we treat and provide medical solutions for healtcare providers. Specializing in electo- mechanical therapeutic physical therapy apparatuses. Proposes to develop our new product line The Trigger Point Neuromucular Therapy Device will be in 3 models (NTD 100, NTD 1000 and NTD 2000) . These product will be manufactured in a consumer, and professional model, for home and clinical environments.
Our product is patent pending, with a utility patent application on file, we are looking to partner with all interested manufacturers.
All interested medical manufacturers who are looking to increase their portfolio is welcome to partner with us to bring this new innovative technology. All are welcome to inquire about our products. Please send us a message from our contact page.
GDTI is currently seeking pre-seed funding to begin our project proof of concept phase and prototype development. Once funding is achieve our team of engineers will begin the following task below so that we can build a prototype for an interested hospital to test, validate our proof of concept and conduct clinical trials. We are currently working on modification of our product designs.
-We will be testing feasibility and proof of concept and develop a prototype
-Prototype Development (10)
Our team of experts are conducting some of the following tasks below
We can provide an interested manufacturer with a non-functional prototype - Business proposal- 3D model, 3D drawings and manufacturer drawings for this product.
New Innovation and Technology NTD 1000
Research are showing trigger point injections are breaking down muscle tissue. A New non invasive treatment for treating myofascial trigger points the leading causing of chronic pain.
Providers in the industry of pain management such as: Osteopaths, Neurologist, Physiatrist, Physical Therapists, Massage Therapists, Chiropractors, Acupuncturists, and pain management doctors, will be able to improve their pain management treatments for patients that suffer from chronic musculoskeletal and neuromuscular pain.
Now is a great time to invest in a new innovation that is about to hit the medical industry. The Industry annual projection is $750 million to $1.5 Billion.
The medical physiotherapy device market wast valued at $3.08B in 2016